NCT07546864 Comparative Effects of Mirror Therapy and Cognitive Orientation to Daily Occupational Performance in Stroke: A Randomized Controlled Trial
| NCT ID | NCT07546864 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hacettepe University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 45 participants |
| Start Date | 2026-02-15 |
| Primary Completion | 2026-05-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 45 participants in total. It began in 2026-02-15 with a primary completion date of 2026-05-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the effectiveness of three rehabilitation approaches in individuals with stroke: mirror therapy (MT), cognitive orientation to daily occupational performance (CO-OP), and conventional occupational therapy (COT), all combined with robotic balance training. A total of 45 individuals with subacute and chronic stroke will be randomly assigned to one of three groups. Each group will receive 4 weeks of intervention (5 sessions per week), followed by a 3-month follow-up period. Outcomes related to motor function, somatosensory function, activities of daily living, participation, and quality of life will be assessed at baseline, after intervention, and at follow-up. The study aims to determine which intervention approach is more effective in improving functional outcomes in individuals with stroke.
Eligibility Criteria
Inclusion Criteria: * \- Individuals diagnosed with ischemic or hemorrhagic stroke * Age 18 years and older * Subacute (3-6 months post-stroke) or chronic stage (6-12 months post-stroke) * Brunnstrom Motor Recovery Stage ≥3 for upper extremity, ≥4 for hand, and ≥4 for lower extremity * Mini-Mental State Examination (MMSE) score ≥24 * No severe visual, orthopedic, or additional neurological impairments * Not participating in another study during the research period * Voluntary consent to participate in the study Exclusion Criteria: * \- Poor motor coordination or major medical problems that would prevent participation * Presence of Wernicke's aphasia * Botulinum toxin injection within the last 3 months * Psychiatric conditions that may interfere with participation (e.g., depression, ongoing psychiatric treatment, low motivation)
Contact & Investigator
Gokcen Akyurek, Associate Professor
PRINCIPAL INVESTIGATOR
Hacettepe University
Frequently Asked Questions
Who can join the NCT07546864 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07546864 currently recruiting?
Yes, NCT07546864 is actively recruiting participants. Contact the research team at nurtenncek@gmail.com for enrollment information.
Where is the NCT07546864 trial being conducted?
This trial is being conducted at Bayburt, Turkey (Türkiye).
Who is sponsoring the NCT07546864 clinical trial?
NCT07546864 is sponsored by Hacettepe University. The principal investigator is Gokcen Akyurek, Associate Professor at Hacettepe University. The trial plans to enroll 45 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.